These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. HDL-C levels modify the association between C-reactive protein and coronary artery calcium score. Sung KC; Cho EJ; Lim YH; Shin J; Pyun WB; Kang SM; Rosenson RS Nutr Metab Cardiovasc Dis; 2014 Nov; 24(11):1240-5. PubMed ID: 25096924 [TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and coronary artery calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Reilly MP; Wolfe ML; Localio AR; Rader DJ; Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1851-6. PubMed ID: 12933535 [TBL] [Abstract][Full Text] [Related]
7. The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study. Gupta NK; de Lemos JA; Ayers CR; Abdullah SM; McGuire DK; Khera A J Am Coll Cardiol; 2012 Sep; 60(13):1148-55. PubMed ID: 22939555 [TBL] [Abstract][Full Text] [Related]
8. Adipokines and severity and progression of coronary artery calcium: Findings from the Rancho Bernardo Study. Larsen BA; Laughlin GA; Cummins K; Barrett-Connor E; Wassel CL Atherosclerosis; 2017 Oct; 265():1-6. PubMed ID: 28825974 [TBL] [Abstract][Full Text] [Related]
9. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides. Seven E Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487 [TBL] [Abstract][Full Text] [Related]
10. Increased oral inflammation, leukocytes, and leptin, and lower adiponectin in overweight or obesity. Thanakun S; Pornprasertsuk-Damrongsri S; Izumi Y Oral Dis; 2017 Oct; 23(7):956-965. PubMed ID: 28513060 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. Abdullah AR; Hasan HA; Raigangar VL Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443 [TBL] [Abstract][Full Text] [Related]
13. Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes. Qasim AN; Budharaju V; Mehta NN; St Clair C; Farouk S; Braunstein S; Schutta M; Iqbal N; Rader DJ; Reilly MP Clin Endocrinol (Oxf); 2011 Jan; 74(1):44-50. PubMed ID: 20874770 [TBL] [Abstract][Full Text] [Related]
14. Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis. Delgado C; Chertow GM; Kaysen GA; Dalrymple LS; Kornak J; Grimes B; Johansen KL Am J Kidney Dis; 2017 Dec; 70(6):817-825. PubMed ID: 28870376 [TBL] [Abstract][Full Text] [Related]
15. Leptin, adiponectin, and obesity among Caucasian and Asian women. Conroy SM; Chai W; Lim U; Franke AA; Cooney RV; Maskarinec G Mediators Inflamm; 2011; 2011():253580. PubMed ID: 21331287 [TBL] [Abstract][Full Text] [Related]
16. Adiponectin gene expression and adipocyte NF-kappaB transcriptional activity in elderly overweight and obese women: inter-relationships with fat distribution, hs-CRP, leptin and insulin resistance. Zamboni M; Di Francesco V; Garbin U; Fratta Pasini A; Mazzali G; Stranieri C; Zoico E; Fantin F; Bosello O; Cominacini L Int J Obes (Lond); 2007 Jul; 31(7):1104-9. PubMed ID: 17325687 [TBL] [Abstract][Full Text] [Related]
17. Leptin, adiponectin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blacks with and without coronary artery disease. Ntyintyane L; Panz V; Raal FJ; Gill G Metab Syndr Relat Disord; 2009 Jun; 7(3):243-8. PubMed ID: 19462476 [TBL] [Abstract][Full Text] [Related]
19. Relationship of obesity with serum concentrations of leptin, CRP and IL-6 in breast cancer survivors. Babaei Z; Moslemi D; Parsian H; Khafri S; Pouramir M; Mosapour A J Egypt Natl Canc Inst; 2015 Dec; 27(4):223-9. PubMed ID: 26462194 [TBL] [Abstract][Full Text] [Related]
20. Epidemiological evidence against a role for C-reactive protein causing leptin resistance. Rutter MK; Sattar N; Tajar A; O'Neill TW; Lee DM; Bartfai G; Boonen S; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Vanderschueren D; Lowe G; O'Rahilly S; Morris RW; Wu FC; Wannamethee SG; Eur J Endocrinol; 2013 Jan; 168(1):101-6. PubMed ID: 23047304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]